Stephen Schleicher, MD, MBA featured in AJMCtv October 2019

Read full article HERE. AJMC®TV interviews let you catch up on what’s new and important about changes in healthcare, with insights from key decision makers—from the clinician, to the health plan leader, to the regulator. Stephen Schleicher, MD, MBA, Medical Oncologist, Tennessee Oncology What are your thoughts on the proposed Radiation Oncology Model and the fact that CMS wants […]

Read More

What Incentivized These Oncology Clinics To Embrace Biosimilars?

Read original article HERE. So far, 2019 has been one of the wackier years in the trajectory of the U.S. biosimilar space. It’s been the year in which the entire purpose of the biosimilar industry has been called into question. But it was also the year we started hearing how a number of organizations and […]

Read More